Provider
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
The company will use the funds to scale its growth within healthcare systems and expand its AI innovation.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Fabric will use MeMD's virtual urgent, behavioral and primary care offerings to expand its employer-focused strategy.
Also, insurtech company Huize from China is expanding to Southeast Asia.
The company will use the funds to expand its employer-focused offerings into Florida.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
EvolutionaryScale's biology-focused language models for drug discovery and therapeutic development will be available to AWS customers.
The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.
The acquisition will see the publicly traded healthcare-navigation company become a privately held business.